Gene-targeted ovarian cancer drug also treats prostate cancer
A drug that targets genetic mutations in ovarian cancer has been found to work in men with prostate cancer with similar mutations, according to a new study...
A gene on human chromosome 13, which instructs the cell to make a protein that normally helps to repair damaged DNA and suppress cell growth. A person who inherits certain mutations in a BRCA2 gene has a higher risk of getting breast cancer, ovarian cancer and certain other types of cancer.
A drug that targets genetic mutations in ovarian cancer has been found to work in men with prostate cancer with similar mutations, according to a new study...
An isolated gene sequence cannot be patented, Australia's highest court has unanimously ruled. It is the latest and final decision in litigation that has lasted over five years...
Researchers have found that tests for multiple breast and ovarian cancer risk genes can be used to inform treatment decisions for women with personal or family history for such cancers...
by Jenny Sharpe
Researchers have called for mass screening of women in their 30s to detect cancer-causing mutations...
A US company has announced a low-cost genetic test for breast cancer...
Scientists in Iceland have produced a comprehensive portrait of the nation's genetic makeup...
by Selene Kaye
On 12 May, the American Civil Liberties Union (ACLU) and the Public Patent Foundation filed a lawsuit challenging the US government's practice of granting patents on human genes - specifically, the BRCA1 and BRCA2 genes, which are associated with breast and ovarian cancer. In the last 20 or so years the...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.